Publicaciones en las que colabora con Andrés Canut Blasco (36)

2024

  1. Does selective digestive decontamination (SDD) increase antibiotic resistance? Long-term comparison of two intensive care units (with and without SDD) of the same tertiary hospital

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 5, pp. 885-893

  2. Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 404-416

  3. Streptococcus pneumoniae eta Haemophilus influenzae bakterio-espezieek eragindako infekzio inbaditzaile eta ez-inbaditzaileak: txertaketaren eraginak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 45, pp. 71-92

2023

  1. Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study

    The Lancet Microbe, Vol. 4, Núm. 12, pp. e994-e1004

  2. Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study

    Blood Purification, Vol. 52, Núm. 5, pp. 464-473

  3. Extended infusion of piperacillin/tazobactam: pharmacokinetics in critically ill patients

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  4. Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?

    Pharmaceutics, Vol. 15, Núm. 4

  5. ¿Incrementa la descontaminación digestiva selectiva la resistencia a antibióticos? Comparación entre dos Servicios de Medicina Intensiva de un hospital terciario

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2021

  1. Evaluation of the adequacy of the antimicrobial therapy of invasive Haemophilus influenzae infections: A pharmacokinetic/pharmacodynamic perspective

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 2, pp. 65-71

  2. Molecular epidemiology, antimicrobial surveillance, and pk/pd analysis to guide the treatment of neisseria gonorrhoeae infections

    Pharmaceutics, Vol. 13, Núm. 10

  3. Oral calcium fosfomycin: Pharmacokinetic/pharmacodynamic study

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 76-78

  4. Pharmacokinetic/pharmacodynamic analysis of tedizolid phosphate compared to linezolid for the treatment of infections caused by gram-positive bacteria

    Antibiotics, Vol. 10, Núm. 7

  5. Pharmacokinetic/pharmacodynamic evaluation of the antimicrobial therapy of pneumococcal invasive disease in adults in post-PCV13 vaccine period in Madrid, Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 10, pp. 2145-2152

  6. Pseudomonas aeruginosa susceptibility in spain: Antimicrobial activity and resistance suppression evaluation by pk/pd analysis

    Pharmaceutics, Vol. 13, Núm. 11

  7. Quantification of ceftaroline in human plasma using high‐performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic studies

    Pharmaceutics, Vol. 13, Núm. 7

2020

  1. Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 7, pp. 306-311

2019

  1. Antibiotic susceptibility trend before and after long-term use of selective digestive decontamination: a 16 year ecological study

    The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 8, pp. 2289-2294

  2. Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 121-129

  3. Deciphering pharmacokinetics and pharmacodynamics of fosfomycin

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 32, pp. 19-24

  4. Pharmacokinetic/pharmacodynamic analysis as a tool for surveillance of the activity of antimicrobials against Pseudomonas aeruginosa strains isolated in critically ill patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 6, pp. 380-386